Preoperative Oral Antibiotics With vs Without Mechanical Bowel Preparation to Reduce Surgical Site Infections Following Colonic Resection: an International Randomized Controlled Trial.

NCT ID: NCT04161599

Last Updated: 2022-04-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

968 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-01

Study Completion Date

2024-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The ORALEV Study found that preoperative oral antibiotics can reduce the incidence of surgical site infections after colonic resection, compared with no preparation.

The role of mechanical bowel preparation in patients needing colonic surgery is yet to be elucidated.

No randomised controlled trials have assessed the impact of mechanical bowel preparation combined with oral antibiotics on the incidence of surgical site infections after colonic surgery, compared with oral antibiotics only.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

International, multicentre, pragmatic, parallel-group, randomised controlled trial.

Routine antibiotics for the intravenous and oral prophylaxis of colorectal surgery will be used.

Experimental group: Patients undergoing elective colonic surgery that involves colonic resection.

The antibiotic prophylaxis in this group will be composed of:

An oral antibiotic pattern of ciprofloxacin (750mg / 12h, 2 doses) and metronidazole (250mg / 8h, 3 doses) the day before surgery, plus mechanical bowel preparation with Sodium picosulfate, light magnesium oxide, and anhydrous citric acid (10 mg - 3.5 g - 10.97 g per dose/ 2 doses the day before surgery) + An intravenous antibiotics pattern of cefuroxime 1,5 g and metronidazole 1 g at anesthetic induction.

Control group: Patients undergoing elective colonic surgery that involves colonic resection.

The antibiotic prophylaxis in this group will be composed of:

An oral antibiotic pattern of ciprofloxacin (750mg / 12h, 2 doses) and metronidazole (250mg / 8h, 3 doses)

\+ An intravenous antibiotic pattern of cefuroxime 1,5 g and metronidazole 1 gr at anesthetic induction.

In both groups a second intravenous dose of cefuroxime (750mg) will be administered if the intraoperative time prolongs for more than three hours or if there is an intraoperative bleeding over 1000cc.

There will not be a placebo treatment. Subject compliance will be evaluated according to the usual practice in surgical care field

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wounds and Injuries Surgery--Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oral + Parenteral prophylaxis + Mechanical Bowel Preparation

Drug: Extra dosage - cefuroxime (750mg) I.V

Procedure: Colonic Surgery Both groups undergo colonic surgery. This section does not include rectal surgery ( see Inclusion/exclusion criteria)

Drug: Cefuroxime 750mg oral An oral antibiotic pattern of ciprofloxacin (750mg / 12h, 2 doses) the day before surgery.

Drug: Metronidazole 250mg oral An oral antibiotic pattern of metronidazole (250mg / 8h, 3 doses) the day before surgery.

Drug: Sodium picosulfate, magnesium oxide, citric acid anhydrous 15.08 g oral An oral laxative for bowel cleansing (2 doses) the day before surgery.

Drug: Metronidazole 1 g Intravenous An intravenous antibiotic pattern of metronidazole 1 g during anesthetic induction.

Drug: Cefuroxime 1,5 g Intravenous An intravenous antibiotic pattern of cefuroxime 1,5 g during anesthetic induction.

Group Type EXPERIMENTAL

Cefuroxime (750mg) I.V

Intervention Type DRUG

Extra dosage

Colonic Surgery

Intervention Type PROCEDURE

Colonic Surgery

Cefuroxime 750mg oral

Intervention Type DRUG

Oral prophylaxis

Metronidazole 250 MG Oral Tablet [Flagyl]

Intervention Type DRUG

Oral prophylaxis

Metronidazole 1 g Intravenous

Intervention Type DRUG

IV prophylaxis

Cefuroxime 1,5 g Intravenous

Intervention Type DRUG

IV prophylaxis

Sodium picosulfate, light magnesium oxide, anhydrous citric acid 10 mg/3.5 g/10.97 g Oral

Intervention Type DRUG

Laxative for bowel cleansing

Oral + Parenteral prophylaxis

Drug: Extra dosage - cefuroxime (750mg) I.V In both groups a second intravenous dose of cefuroxime (750mg) will be administered if the intraoperative time elongates more than three hours or there is an intraoperative bleeding over 1000cc

Procedure: Colonic Surgery Both groups undergo colonic surgery. This section does not include rectal surgery ( see Inclusion/exclusion criteria)

Drug: Cefuroxime 750mg oral An oral antibiotic pattern of ciprofloxacin (750mg / 12h, 2 doses) the day before surgery.

Drug: Metronidazole 250mg oral An oral antibiotic pattern of metronidazole (250mg / 8h, 3 doses) the day before surgery.

Drug: Metronidazole 1 gr Intravenous An intravenous antibiotic pattern of metronidazole 1 g during anesthetic induction.

Drug: Cefuroxime 1,5 g Intravenous An intravenous antibiotic pattern of cefuroxime 1,5 g during anesthetic induction.

Group Type ACTIVE_COMPARATOR

Cefuroxime (750mg) I.V

Intervention Type DRUG

Extra dosage

Colonic Surgery

Intervention Type PROCEDURE

Colonic Surgery

Cefuroxime 750mg oral

Intervention Type DRUG

Oral prophylaxis

Metronidazole 250 MG Oral Tablet [Flagyl]

Intervention Type DRUG

Oral prophylaxis

Metronidazole 1 g Intravenous

Intervention Type DRUG

IV prophylaxis

Cefuroxime 1,5 g Intravenous

Intervention Type DRUG

IV prophylaxis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cefuroxime (750mg) I.V

Extra dosage

Intervention Type DRUG

Colonic Surgery

Colonic Surgery

Intervention Type PROCEDURE

Cefuroxime 750mg oral

Oral prophylaxis

Intervention Type DRUG

Metronidazole 250 MG Oral Tablet [Flagyl]

Oral prophylaxis

Intervention Type DRUG

Metronidazole 1 g Intravenous

IV prophylaxis

Intervention Type DRUG

Cefuroxime 1,5 g Intravenous

IV prophylaxis

Intervention Type DRUG

Sodium picosulfate, light magnesium oxide, anhydrous citric acid 10 mg/3.5 g/10.97 g Oral

Laxative for bowel cleansing

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients of both genders, aged 18 years or above, with colonic disease without contraindications to surgical treatment, diagnosed with neoplasia or diverticular disease (diverticulosis with indication to elective surgery: stricture, chronic constipation), patients for whom a segmental or total colectomy is indicated.
* Patients who voluntarily accept to join the study and sign a dedicated written consent.
* Capability of understanding the study and take the medications prescribed.

Exclusion Criteria

* Patients undergoing urgent surgery or no elective admission
* Patients who refuse to participate
* Patients with rectal disease or neoplasia
* Patients with pre-existing intrabdominal sepsis (abscess, acute diverticulitis)
* Patients who received preoperative antibiotic treatment for any other reasons during the two weeks before surgery
* Patients with Crohn's disease or ulcerative colitis
* Patients unlikely to adhere to the treatment prescribed
* Patients with allergy or contraindication to the medications used in the study
* Patients who need mechanical bowel preparation
* Patients with contraindication to bowel preparation used in the study (Citrafleet®):
* Patients with kidney failure needing haemodialysis or with hypermagnesemia
* Patients with severe heart failure
* Patients with gastric or duodenal ulcer
* Patients with mechanical obstruction
* Patients with toxic megacolon
* Patients with ascites or rhabdomyolysis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Universitari Vall d'Hebron Research Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eloy Espín-Basany, MD PhD

Role: STUDY_CHAIR

Hospital Universitario Valle de Hebron, Barcelona

Gianluca Pellino, MD, PhD

Role: STUDY_DIRECTOR

Hospital Universitario Valle de Hebron, Barcelona

Alejandro Solís-Peña, MD, PhD

Role: STUDY_DIRECTOR

Hospital Universitario Valle de Hebron, Barcelona

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jinling Hospital

Nanjing, , China

Site Status RECRUITING

General University Hospital of Patras

Pátrai, , Greece

Site Status RECRUITING

Humanitas Research Hospital

Rozzano, , Italy

Site Status RECRUITING

Tomsk Oncological Hospital

Tomsk, , Russia

Site Status RECRUITING

Hospital General Universitario Vall d´Hebron

Barcelona, Barcelona, Spain, Spain

Site Status RECRUITING

Hospital de Bellvitge

Barcelona, Hospitalet de Llobregat, Barcelona, Spain, Spain

Site Status RECRUITING

Hospital Universitario Cruces

Cruces, , Spain

Site Status RECRUITING

Hospital Universitario Lucus Augusti

Lugo, , Spain

Site Status RECRUITING

Hospital Universitario Ramón y Cajal

Madrid, , Spain

Site Status RECRUITING

Royal Marsden Hospital, Imperial College of London

London, , United Kingdom

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China Greece Italy Russia Spain United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Eloy Espín-Basany, MD PhD

Role: CONTACT

934 893 000 ext. 6587

Gianluca Pellino, MD, PhD

Role: CONTACT

934 893 000 ext. 6587

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Huajian Ren

Role: primary

Francesck Mulita

Role: primary

Antonino Spinelli

Role: primary

Annalisa Maroli

Role: backup

Eugeniy Drozdov

Role: primary

Eloy Espín Basany, MD PhD

Role: primary

934 893 000 ext. 6587

María Martínez Lopez, MD

Role: backup

Sebastiano Biondo, MD PhD

Role: primary

932 607 500

José María García González

Role: primary

Manuel Muinelo

Role: primary

Juan Ocaña Jiménez

Role: primary

Christos Kontovounisios

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Pellino G, Solis-Pena A, Kraft M, Huguet BM, Espin-Basany E. Preoperative oral antibiotics with versus without mechanical bowel preparation to reduce surgical site infections following colonic resection: Protocol for an international randomized controlled trial (ORALEV2). Colorectal Dis. 2021 Aug;23(8):2173-2181. doi: 10.1111/codi.15681. Epub 2021 May 12.

Reference Type RESULT
PMID: 33872448 (View on PubMed)

Willis MA, Toews I, Soltau SL, Kalff JC, Meerpohl JJ, Vilz TO. Preoperative combined mechanical and oral antibiotic bowel preparation for preventing complications in elective colorectal surgery. Cochrane Database Syst Rev. 2023 Feb 7;2(2):CD014909. doi: 10.1002/14651858.CD014909.pub2.

Reference Type DERIVED
PMID: 36748942 (View on PubMed)

Koskenvuo L, Sallinen V. Preoperative oral antibiotics in colon surgery. Lancet Gastroenterol Hepatol. 2020 Sep;5(9):801-802. doi: 10.1016/S2468-1253(20)30203-X. No abstract available.

Reference Type DERIVED
PMID: 32818460 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-004283-21

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mechanical Bowel Prep Randomized Study
NCT04931173 NOT_YET_RECRUITING NA